Ignite Creation Date:
2024-05-06 @ 4:05 AM
Last Modification Date:
2024-10-26 @ 11:43 AM
Study NCT ID:
NCT02450903
Status:
COMPLETED
Last Update Posted:
2021-03-30
First Post:
2015-05-08
Brief Title:
LDK378 in Patients With ALK Positive NSCLC Previously Treated With Alectinib
Sponsor:
Organization:
Novartis